These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases. Attia MS; Yahya A; Monaem NA; Sabry SA Saudi Pharm J; 2023 Mar; 31(3):417-432. PubMed ID: 37026045 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential. Bai Y; Su X; Piao L; Jin Z; Jin R Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055 [TBL] [Abstract][Full Text] [Related]
7. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics. Sharifi-Rad M; Lankatillake C; Dias DA; Docea AO; Mahomoodally MF; Lobine D; Chazot PL; Kurt B; Tumer TB; Moreira AC; Sharopov F; Martorell M; Martins N; Cho WC; Calina D; Sharifi-Rad J J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32276438 [TBL] [Abstract][Full Text] [Related]
8. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases. Han S; Gim Y; Jang EH; Hur EM Front Cell Neurosci; 2022; 16():1083159. PubMed ID: 36605616 [TBL] [Abstract][Full Text] [Related]
10. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases. Bai X; Bian Z; Zhang M Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130 [TBL] [Abstract][Full Text] [Related]
11. Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases. Nainu F; Mamada SS; Harapan H; Emran TB Adv Exp Med Biol; 2023; 1411():39-70. PubMed ID: 36949305 [TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease. Zhang M; Bian Z Front Aging Neurosci; 2021; 13():691512. PubMed ID: 34322012 [TBL] [Abstract][Full Text] [Related]
13. The involvement of microRNAs in neurodegenerative diseases. Maciotta S; Meregalli M; Torrente Y Front Cell Neurosci; 2013 Dec; 7():265. PubMed ID: 24391543 [TBL] [Abstract][Full Text] [Related]
14. Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis. Miteva D; Vasilev GV; Velikova T Antibodies (Basel); 2023 Dec; 12(4):. PubMed ID: 38131803 [TBL] [Abstract][Full Text] [Related]
15. Ion Channels in Neurological Disorders. Kumar P; Kumar D; Jha SK; Jha NK; Ambasta RK Adv Protein Chem Struct Biol; 2016; 103():97-136. PubMed ID: 26920688 [TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Review of Therapeutic Compounds from Plants for Neurodegenerative Diseases. P DS; K A; S M; Gopinath SCB; Raman P Curr Med Chem; 2024 Feb; ():. PubMed ID: 38367263 [TBL] [Abstract][Full Text] [Related]
17. miRNAs as biomarkers of neurodegenerative disorders. Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293 [TBL] [Abstract][Full Text] [Related]
18. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle. Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490 [TBL] [Abstract][Full Text] [Related]
19. Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application. Xu J; Du W; Zhao Y; Lim K; Lu L; Zhang C; Li L Acta Pharm Sin B; 2022 Jun; 12(6):2778-2789. PubMed ID: 35755284 [TBL] [Abstract][Full Text] [Related]